Ethan Webb

Ethan Webb

Staff Writer, Acuity Media Network

Ethan Webb is a staff writer at Acuity Media Network, where he covers the business of autism and behavioral health care. His reporting examines how financial pressures, policy changes, and market consolidation shape the ABA industry — and what that means for providers and families. Ethan holds a BFA in Creative Writing from Emerson College and brings more than seven years of professional writing and editing experience spanning healthcare, finance, and business journalism. He has served as Managing Editor of Dental Lifestyles Magazine and has ghostwritten multiple titles that reached the USA Today and Wall Street Journal bestseller lists.

LinkedIn Profile

Articles by Ethan Webb

Methadone Reform Would Break the Clinic Monopoly in Opioid Treatment. A Bipartisan Bill Would Let a Pharmacy Fill the Prescription, and the Clinics Are Fighting It.

Regulation · Aug 10, 2026

Methadone Reform Would Break the Clinic Monopoly in Opioid Treatment. A Bipartisan Bill Would Let a Pharmacy Fill the Prescription, and the Clinics Are Fighting It.

Bipartisan federal legislation reintroduced as MOTAA 2.0 threatens to disrupt the decades-old monopoly held by specialized Opioid Treatment Programs (OTPs).…

Autism-Friendly Dental Care in New Jersey Runs on Individual Heroics. Autism New Jersey and the New Jersey Dental Foundation Are Trying to Build a System.

Regulation · Aug 10, 2026

Autism-Friendly Dental Care in New Jersey Runs on Individual Heroics. Autism New Jersey and the New Jersey Dental Foundation Are Trying to Build a System.

Dental care remains the single most frequently reported unmet healthcare need among autistic individuals. In New Jersey, where CDC surveillance…

Digital Therapeutics Got FDA Clearance Years Ago and Went Bankrupt Anyway. Now Medicare Is Finally Paying for Them, and the Business Case Is Being Tested for the First Time.

Technology · Aug 7, 2026

Digital Therapeutics Got FDA Clearance Years Ago and Went Bankrupt Anyway. Now Medicare Is Finally Paying for Them, and the Business Case Is Being Tested for the First Time.

The bankruptcy of Pear Therapeutics established a stark lesson for digital medicine: FDA clearance proves clinical safety, but reimbursement determines…

Small ABA Practice Closures Leave Almost No Public Record While the Industry Counts Every Acquisition. Fixed Compliance Costs Land Hardest Where There Is No Scale.

Regulation · Aug 7, 2026

Small ABA Practice Closures Leave Almost No Public Record While the Industry Counts Every Acquisition. Fixed Compliance Costs Land Hardest Where There Is No Scale.

While healthcare M&A trackers meticulously document every private equity acquisition in the Applied Behavior Analysis (ABA) space, no dataset monitors…

Naloxone Has Never Been Cheaper, and the Money to Distribute It Is Disappearing. A Life-Saving Drug Falls to Nineteen Dollars Just as Federal Harm Reduction Funding Retreats.

Regulation · Aug 6, 2026

Naloxone Has Never Been Cheaper, and the Money to Distribute It Is Disappearing. A Life-Saving Drug Falls to Nineteen Dollars Just as Federal Harm Reduction Funding Retreats.

The economics of overdose prevention are diverging sharply from public health policy. While over-the-counter regulatory approvals and state purchasing initiatives…

1 3 4 5 6 7 51